MHRAsafety guidance72% confidence
Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07
Source: MHRA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (liver cancer) as Imfinzi+Imjudo shows significant PFS improvement in early liver cancer trial.
Regulatory Analysis
Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.
Supporting Context
- Therapeutic area
- Oncology · Liver Cancer
- Sub-indication
- Liver Cancer
Related signal: Imfinzi+Imjudo shows significant PFS improvement in early liver cancer trial